Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

The microbiome meets nanotechnology: Opportunities and challenges in developing new diagnostic devices

Fuentes-Chust C, Parolo C, Rosati G, Rivas L, Perez-Toralla K, Simon S, de Lecuona I, Junot C, Trebicka J, Merkoçi A.

Adv Mater 2021, 33(18): e2006104

DOI: 10.1002/adma.202006104

Liver transplantation as a cornerstone treatment for acute-on-chronic liver failure

Schulz MS, Gu W, Schnitzbauer AA, Trebicka J.

Transpl Int 2022, 35: 10108

DOI: 10.3389/ti.2022.10108

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis

Pieper CC, Feißt A, Meyer C, Luetkens J, Praktiknjo M, Trebicka J, Attenberger U, Jansen C.

Sci Rep 2021, 11(1): 7065

DOI: 10.1038/s41598-021-86006-7

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis

Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A.

JHEP Rep 2021, 3(3): 100287

DOI: 10.1016/j.jhepr.2021.100287

Elective surgery but not transjugular intrahepatic portosystemic shunt precipitates acute-on-chronic liver failure

Chang J, Bamarni A, Böhling N, Zhou X, Klein LM, Meinke J, Duerr GD, Lingohr P, Wehner S, Brol MJ, Rockstroh JK, Kalff JC, Manekeller S, Meyer C, Spengler U, Jansen C, Arroyo V, Strassburg CP, Trebicka J, Praktiknjo M.

Hepatol Commun 2021, 5(7): 1265–1277

DOI: 10.1002/hep4.1712

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

Arroyo V, Angeli P, Moreau R, Jalan R, Clària J, Trebicka J, Fernández J, Gustot T, Caraceni P, Bernardi M; investigators from the EASL-CLIF Consortium, Grifols Chair and European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol. 2021, 74(3): 670–685

DOI: 10.1016/j.jhep.2020.11.048

Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure

Trebicka J, Bork P, Krag A, Arumugam M.

Nat Rev Gastroenterol Hepatol 2021, 18(3): 167–180

DOI: 10.1038/s41575-020-00376-3

Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF

Weiss E, de la Grange P, Defaye M, Lozano JJ, Aguilar F, Hegde P, Jolly A, Moga L, Sukriti S, Agarwal B, Gurm H, Tanguy M, Poisson J, Clària J, Abback PS, Périanin A, Mehta G, Jalan R, Francoz C, Rautou PE, Lotersztajn S, Arroyo V, Durand F, Moreau R.

Front Immunol 2021, 11: 619039

DOI: 10.3389/fimmu.2020.619039

Albumin protects the liver from tumor necrosis factor α-induced immunopathology

Duran-Güell M, Flores-Costa R, Casulleras M, López-Vicario C, Titos E, Díaz A, Alcaraz-Quiles J, Horrillo R, Costa M, Fernández J, Arroyo V, Clària J.

FASEB J 2021, 35(2): e21365

DOI: 10.1096/fj.202001615RRR

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P; International Club of Ascites Global Study Group.

J Hepatol 2021, 74(2): 330-339

DOI: 10.1016/j.jhep.2020.07.046

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024